Apixaban in bridge to transplant and destination LVAD ‐ rationale and study design: the ApixiVAD trial
Abstract Aims Use of novel anticoagulation in mechanical circulatory support is controversial. We report the rationale and design of the ApixiVad pilot trial, a pilot study testing the safety of apixaban as an anticoagulant in patients bridged to transplant (BTT) or for destination (DT) with Heartma...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2024-08-01
|
| Schriftenreihe: | ESC Heart Failure |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/ehf2.14782 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|